Cargando…

Time-dependent endpoints as predictors of overall survival in multiple myeloma

BACKGROUND: Supporting health care sector decisions using time-dependent endpoints (TDEs) such as time to progression (TTP), progression-free survival (PFS), and event-free survival (EFS) remains controversial. This study estimated the quantitative relationship between median TDE and median overall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Félix, Jorge, Aragão, Filipa, Almeida, João M, Calado, Frederico JM, Ferreira, Diana, Parreira, António BS, Rodrigues, Ricardo, Rijo, João FR
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607860/ https://www.ncbi.nlm.nih.gov/pubmed/23497363 http://dx.doi.org/10.1186/1471-2407-13-122

Ejemplares similares

Surrogate Endpoints as Predictors of Overall Survival in Metastatic Urothelial Cancer: A Trial-level Analysis
por: Ghali, Fady, et al.
Publicado: (2022)

Association of response endpoints with survival outcomes in multiple myeloma
por: Lonial, S, et al.
Publicado: (2014)

Review of meta-analyses evaluating surrogate endpoints for overall survival in oncology
por: Sherrill, Beth, et al.
Publicado: (2012)

Boosting Immunity against Multiple Myeloma
por: Lopes, Raquel, et al.
Publicado: (2021)

The Immune Microenvironment in Multiple Myeloma: Friend or Foe?
por: Lopes, Raquel, et al.
Publicado: (2021)

Evaluating relapse-free survival as an endpoint for overall survival in adjuvant immunotherapy trials
por: Li, Yuanfang, et al.
Publicado: (2023)

Characterization and Behaviour of Silica Engineered Nanocontainers in Low and High Ionic Strength Media
por: Ferreira, Violeta, et al.
Publicado: (2023)

Association Between Tumor Progression Endpoints and Overall Survival in Patients with Advanced Neuroendocrine Tumors
por: Ter‐Minassian, Monica, et al.
Publicado: (2017)

Searching for potential surrogate endpoints of overall survival in clinical trials for patients with prostate cancer
por: Maeda, Hideki, et al.
Publicado: (2021)

Surrogate Endpoints for Overall Survival in Immune-Oncology Trials of Advanced Gastro-Esophageal Carcinoma
por: Li, Yuan Fang, et al.
Publicado: (2022)

Endocrine-Sensitive Physical Endpoints in Newborns: Ranges and Predictors
por: Shah, Rachana, et al.
Publicado: (2020)

Liquid biopsies for multiple myeloma in a time of precision medicine
por: Ferreira, Bruna, et al.
Publicado: (2020)

Sleeping Sickness: A Tale of Two Clocks
por: Rijo-Ferreira, Filipa, et al.
Publicado: (2020)

Genomics of circadian rhythms in health and disease
por: Rijo-Ferreira, Filipa, et al.
Publicado: (2019)

Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer
por: Cicero, Giuseppe, et al.
Publicado: (2018)

Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma
por: Song, Ga-Young, et al.
Publicado: (2020)

Predictors of Long‐term Clinical Endpoints in Patients With Refractory Angina
por: Povsic, Thomas J., et al.
Publicado: (2015)

Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma
por: Han, Kelong, et al.
Publicado: (2015)

Surrogate endpoints for overall survival in randomised controlled trials of localised osteosarcoma: A meta-analytic evaluation
por: Tanaka, Kazuhiro, et al.
Publicado: (2020)

Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma
por: Liu, Hua, et al.
Publicado: (2022)

Exploration of modified progression-free survival as a novel surrogate endpoint for overall survival in immuno-oncology trials
por: Wang, Zi-Xian, et al.
Publicado: (2021)

Long-term survival in multiple myeloma
por: João, Cristina, et al.
Publicado: (2014)

Organizational commitment, psychometric qualities and invariance of the Meyer and Allen Questionnaire for Portuguese Nurses
por: Neves, Teresa, et al.
Publicado: (2018)

Circadian rhythms in parasites
por: Rijo-Ferreira, Filipa, et al.
Publicado: (2017)

Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial
por: Packer, Milton, et al.
Publicado: (2021)

Surrogate endpoints.
por: Ellenberg, S. S.
Publicado: (1993)

The Keynesian Endpoint
por: Crescenzi, Tony
Publicado: (2010)

Endpoint security
por: Kadrich, Mark
Publicado: (2007)

Surrogate endpoints for overall survival in digestive oncology trials: which candidates? A questionnaires survey among clinicians and methodologists
por: Methy, Nicolas, et al.
Publicado: (2010)

Potential surrogate endpoints for overall survival in locoregionally advanced nasopharyngeal carcinoma: an analysis of a phase III randomized trial
por: Chen, Yu-Pei, et al.
Publicado: (2015)

Progression-free survival as a surrogate endpoint for overall survival in modern ovarian cancer trials: a meta-analysis
por: Sjoquist, Katrin M., et al.
Publicado: (2018)

Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma
por: Cabibbo, Giuseppe, et al.
Publicado: (2020)

Consideration of Surrogate Endpoints for Overall Survival Associated With First-Line Immunotherapy in Extensive-Stage Small Cell Lung Cancer
por: Zhang, Shuang, et al.
Publicado: (2021)

Overall Disability Response Score: An integrated endpoint to assess disability improvement and worsening over time in patients with multiple sclerosis
por: Chang, Ih, et al.
Publicado: (2022)

P821: HIGH-DIMENSIONAL SPECTRAL CYTOMETRY CHARACTERIZATION OF THE CIRCULATING IMMUNE CELL PROFILE IN ASYMPTOMATIC AND SYMPTOMATIC MYELOMA PATIENTS.
por: Caetano, Joana, et al.
Publicado: (2023)

Trends in overall survival and costs of multiple myeloma, 2000–2014
por: Fonseca, R, et al.
Publicado: (2017)

P837: MULTIPLE MYELOMA AND ADJACENT NK CELLS CAN EXPRESS THE MACHINERY TO INTEGRATE NEURONAL SIGNALS
por: Filipa Barahona, Ana, et al.
Publicado: (2023)

Scale of adverse events associated to nursing practices: a psychometric study in Portuguese hospital context
por: Neves, Teresa, et al.
Publicado: (2018)

Organizational Commitment and Intention to Leave of Nurses in Portuguese Hospitals
por: Neves, Teresa, et al.
Publicado: (2022)

Patient-centered endpoints in trials of ICU sedation
por: Salluh, Jorge IF, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_h8itekq0mu4aks1h65tjf3u0uv